Cargando…

Update on the clinical utility and optimal use of cefditoren

This article reviews and updates published data on cefditoren. The in vitro activity of cefditoren and its potential pharmacokinetic/pharmacodynamic adequacy to cover emerging resistance phenotypes in the present decade is reviewed. Cefditoren’s in vitro activity against most prevalent bacterial res...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barberán, José, Aguilar, Lorenzo, Giménez, María-José
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3367410/ https://www.ncbi.nlm.nih.gov/pubmed/22675264 http://dx.doi.org/10.2147/IJGM.S25989

Ejemplares similares

Cefditoren in upper and lower community-acquired respiratory tract infections
por: Soriano, Francisco, et al.
Publicado: (2011)

Revisiting cefditoren for the treatment of community-acquired infections caused by human-adapted respiratory pathogens in adults
por: Giménez, María-José, et al.
Publicado: (2018)

High Protein Binding and Cidal Activity against Penicillin-Resistant S. pneumoniae: A Cefditoren In Vitro Pharmacodynamic Simulation
por: Sevillano, David, et al.
Publicado: (2008)

Cefditoren and Ceftriaxone Enhance Complement-Mediated Immunity in the Presence of Specific Antibodies against Antibiotic-Resistant Pneumococcal Strains
por: Ramos-Sevillano, Elisa, et al.
Publicado: (2012)

Enhanced In Vivo Activity of Cefditoren in Pre-Immunized Mice against Penicillin-Resistant S. pneumoniae (Serotypes 6B, 19F and 23F) in a Sepsis Model
por: Cafini, Fabio, et al.
Publicado: (2010)

Drug resistance in community-acquired respiratory tract infections: role for an emerging antibacterial
por: Aguilar, Lorenzo, et al.
Publicado: (2010)

Cefditoren pivoxil associated rash and arthralgia in a child
por: Nandy, Manab, et al.
Publicado: (2012)

Cefditoren: Acute generalised exanthematous pustulosis following off label use: case report
Publicado: (2020)

Cefditoren: Comparative efficacy with other antimicrobials and risk factors for resistance in clinical isolates causing UTIs in outpatients
por: Hatzaki, Despina, et al.
Publicado: (2012)

Development and validation of the stability-indicating LC–UV method for the determination of Cefditoren pivoxil
por: Annapurna, M. Mathrusri, et al.
Publicado: (2012)

Identification and Characterization of Hydrolytic Degradation Products of Cefditoren Pivoxil using LC and LC-MS/TOF
por: Gawande, V. T., et al.
Publicado: (2015)

EFFICACY AND TOLERABILITY OF CEFDITOREN PIVOXIL IN UNCOMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS IN INDIAN PATIENTS
por: Manaktala, Charu, et al.
Publicado: (2009)

Preparation and characterization of cefditoren pivoxil-loaded liposomes for controlled in vitro and in vivo drug release
por: Venugopalarao, Gojjala, et al.
Publicado: (2015)

Cefditoren versus levofloxacin in patients with exacerbations of chronic bronchitis: serum inflammatory biomarkers, clinical efficacy, and microbiological eradication
por: Blasi, Francesco, et al.
Publicado: (2013)

Combination of Cefditoren and N-acetyl-l-Cysteine Shows a Synergistic Effect against Multidrug-Resistant Streptococcus pneumoniae Biofilms
por: Llamosí, Mirella, et al.
Publicado: (2022)

A Comparison of Cefditoren Pivoxil 8-12 mg/kg/day and Cefditoren Pivoxil 16-20 mg/kg/day in Treatment of Children With Acute Presumed Bacterial Rhinosinusitis: A Prospective, Randomized, Investigator-Blinded, Parallel-Group Study
por: Poachanukoon, Orapan, et al.
Publicado: (2015)

Rapid and Sensitive Electrochemical Assay of Cefditoren with MWCNT/Chitosan NCs/Fe(2)O(3) as a Nanosensor
por: Aydogdu, Nida, et al.
Publicado: (2022)

T405, a New Penem, Exhibits In Vivo Efficacy against M. abscessus and Synergy with β-Lactams Imipenem and Cefditoren
por: Rimal, Binayak, et al.
Publicado: (2022)

Possible clinical indications of ceftobiprole
por: Barberán, José
Publicado: (2019)

Comparative Study of 5-Day and 10-Day Cefditoren Pivoxil Treatments for Recurrent Group A β-Hemolytic Streptococcus pharyngitis in Children
por: Kikuta, Hideaki, et al.
Publicado: (2009)

Update on the clinical utility and practical use of ropivacaine in Chinese patients
por: Li, Man, et al.
Publicado: (2014)

Clinical utility of circulating tumor cells: an update
por: Vasseur, Antoine, et al.
Publicado: (2020)

Urolithins: a Comprehensive Update on their Metabolism, Bioactivity, and Associated Gut Microbiota
por: García‐Villalba, Rocío, et al.
Publicado: (2022)

Update on the clinical utility of once-daily tacrolimus in the management of transplantation
por: Posadas Salas, Maria Aurora, et al.
Publicado: (2014)

Progress in the clinical development and utilization of vision prostheses: an update
por: Brandli, Alice, et al.
Publicado: (2016)

An update in clinical utilization of photodynamic therapy for lung cancer
por: Wang, Kai, et al.
Publicado: (2021)

Update on optimal use of omalizumab in management of asthma
por: Pelaia, Girolamo, et al.
Publicado: (2011)

Development of Aspergillosis in a cohort of non-neutropenic, non-transplant patients colonised by Aspergillus spp
por: Barberán, José, et al.
Publicado: (2017)

Update on the clinical utility of sildenafil in the treatment of pulmonary arterial hypertension
por: Ramani, Gautam V, et al.
Publicado: (2010)

Update on optimal use of lisdexamfetamine in the treatment of ADHD
por: Madaan, Vishal, et al.
Publicado: (2013)

Repeated Aspergillus isolation in respiratory samples from non-immunocompromised patients not selected based on clinical diagnoses: colonisation or infection?
por: Barberan, Jose, et al.
Publicado: (2012)

Update and clinical utility of the LenSx femtosecond laser in cataract surgery
por: Roberts, Timothy V, et al.
Publicado: (2016)

Update on the clinical utility of an RNA interference-based treatment: focus on Patisiran
por: Rizk, Malak, et al.
Publicado: (2017)

Update on the Utility of Optical Coherence Tomography in the Analysis of the Optic Nerve Head in Highly Myopic Eyes with and without Glaucoma
por: Kudsieh, Bachar, et al.
Publicado: (2023)

Update on the optimal use of voriconazole for invasive fungal infections
por: Lat, Asma, et al.
Publicado: (2011)

Update on the optimal use of bortezomib in the treatment of multiple myeloma
por: Mohan, Meera, et al.
Publicado: (2017)

Factors associated with development of nephrotoxicity in patients treated with vancomycin versus daptomycin for severe Gram-positive infections: A practice-based study
por: Barberán, José, et al.
Publicado: (2019)

Update on the clinical utility of fenofibrate in mixed dyslipidemias: mechanisms of action and rational prescribing
por: Farnier, Michel
Publicado: (2008)

An update on clinical utility of rilpivirine in the management of HIV infection in treatment-naïve patients
por: Putcharoen, Opass, et al.
Publicado: (2013)

An Update on the Genetics of Usher Syndrome
por: Millán, José M., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_dj1pp2dc2branvce6b06un9o2b